6533b85cfe1ef96bd12bc732
RESEARCH PRODUCT
Use of 2 hydroxypropyl-beta-cyclodextrin therapy in two adult Niemann Pick Type C patients
Carmen Alcalá-vicenteInmaculada GaleanoMaría José Company-albirEduardo López-brizFrancisco Pérez-mirallesJuan Eduardo Megías-vericatBonaventura CasanovaAna García-roblesMaría José Fernández-megíaJosé Luis Povedasubject
0301 basic medicineNiemann–Pick disease type CFatal outcomebusiness.industryBeta-CyclodextrinsPharmacologyIntrathecalmedicine.disease03 medical and health sciences2-Hydroxypropyl-beta-cyclodextrin030104 developmental biology0302 clinical medicine2 hydroxypropyl β cyclodextrinNeurologyToxicitymedicineNeurology (clinical)Metabolic diseasebusiness030217 neurology & neurosurgeryyear | journal | country | edition | language |
---|---|---|---|---|
2016-07-01 | Journal of the Neurological Sciences |